Rhabdomyosarcomas in Aging A/J Mice

作者: Roger B. Sher , Gregory A. Cox , Kevin D. Mills , John P. Sundberg

DOI: 10.1371/JOURNAL.PONE.0023498

关键词:

摘要: Rhabdomyosarcomas (RSCs) are skeletal muscle neoplasms found in humans and domestic mammals. The A/J inbred strain developed a high frequency (between 70–80%) of adult pleomorphic type (APT) RSC at >20 months age while BALB/cByJ also develop but less frequently. These invaded surrounding either the axial or proximal appendicular skeleton were characterized by cells with abundant eosinophilic cytoplasm, multiple nuclei, cross striations. diagnosis was confirmed detection alpha-sarcomeric actin myogenin neoplastic using immunocytochemistry. strain, not related BALB/c substrains, is characterised progressive muscular dystrophy homologous to limb-girdle 2B. association between development similar groups those most severely affected suggested that these from abnormal regeneration exacerbated dysferlin mutation. Transcriptome analyses RSCs revealed marked downregulation genes function signaling networks. Non-synonymous coding SNPs Myl1, Abra, Sgca, Ttn, Kcnj12 suggesting may be important pathogenesis RSC. studies suggest A strains mice can useful models for dissecting molecular genetic basis development, progression, ultimately testing novel anticancer therapeutic agents dealing rhabdomyosarcoma.

参考文章(47)
D. L. Dungworth, Ulrich Mohr, C. C. (Charles C.) Capen, Pathobiology of the aging mouse International Life Sciences Institute. ,(1996)
Giuseppe Barbanti-Brodano, Silvia Sabbioni, Carlo M. Croce, Massimo Negrini, GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Research. ,vol. 57, pp. 4493- 4497 ,(1997)
Hans J. Hedrich, The laboratory mouse Elsevier Academic Press. ,(2012)
Stefania Croci, Patrizia Nanni, Annalisa Astolfi, Manuela Iezzi, Emma Di Carlo, Carla De Giovanni, Piero Musiani, Pier Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Research. ,vol. 63, pp. 2728- 2732 ,(2003)
Reginald E. Bittner, Louise V.B. Anderson, Elke Burkhardt, Rumaisa Bashir, Elizabeth Vafiadaki, Silva Ivanova, Thomas Raffelsberger, Isabel Maerk, Harald Höger, Martin Jung, Mohsen Karbasiyan, Maria Storch, Hans Lassmann, Jennifer A. Moss, Keith Davison, Ruth Harrison, Kate M.D. Bushby, André Reis, Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B Nature Genetics. ,vol. 23, pp. 141- 142 ,(1999) , 10.1038/13770
Rong Yuan, Shirng-Wern Tsaih, Stefka B. Petkova, Caralina Marin De Evsikova, Shuqin Xing, Michael A. Marion, Molly A. Bogue, Kevin D. Mills, Luanne L. Peters, Carol J. Bult, Clifford J. Rosen, John P. Sundberg, David E. Harrison, Gary A. Churchill, Beverly Paigen, Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell. ,vol. 8, pp. 277- 287 ,(2009) , 10.1111/J.1474-9726.2009.00478.X
Incidence of Childhood Cancer: Experience of a Decade in a Population-Based Registry Journal of the National Cancer Institute. ,vol. 70, pp. 49- 55 ,(1983) , 10.1093/JNCI/70.1.49
Simona Ognjanovic, Amy M. Linabery, Bridget Charbonneau, Julie A. Ross, Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. ,vol. 115, pp. 4218- 4226 ,(2009) , 10.1002/CNCR.24465
Alexander Fleischmann, Wolfram Jochum, Robert Eferl, James Witowsky, Erwin F Wagner, None, Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell. ,vol. 4, pp. 477- 482 ,(2003) , 10.1016/S1535-6108(03)00280-0